Device Trial Radar · NCT03569111
Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter
Last checked: Nov 20, 2026Latest source record: Nov 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Feb 27, 2019
Primary completion
Oct 28, 2020
Study completion Oct 28, 2020
Sponsor
- Lead sponsor
- Medtronic - MITGPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jun 26, 2018
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this investigation is to characterize the safety and performance of the Emprint™ Ablation Catheter Kit with Thermosphere™ Technology in clinical use. This is a prospective, single-arm, multicenter, non-randomized study. Up to 3 sites in up to 3 countries will enroll up to 30 subjects in total. The study is designed to characterize the safety and performance of the bronchoscopic ablation procedure using the Emprint™ Ablation Catheter Kit with Thermosphere™ Technology.
Conditions
- Cancer, Lung
- Cancer, Metastatic to Lung
Interventions
Bronchoscopic ablation catheterDevice
The Emprint™ Ablation Catheter Kit with Thermosphere™ Technology is deployed endoscopically and will be used to conduct bronchoscopic ablations in the lung using the superDimension™ navigation system.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With AEs Related to the Emprint™ Ablation Catheter Kit With Thermosphere™ TechnologyTime frame: During procedure through 1-month follow-up (an average of 20-40 days post-procedure)
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Prince of Wales Hospital
Hong Kong, Hong Kong
St. Bartholomew's Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.